Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mirus Bio™ TransIT-VirusGEN™ SELECT Transfection Reagent
Large-scale virus production for preclinical and early-phase clinical trials
Supplier: Mirus Bio™ MIR 6730
Description
- Efficient DNA delivery for large-scale production of high-titer virus vectors
- Tested for performance, identity, sterility, endotoxin and mycoplasma
- Exceptional lot-to-lot consistency
- Compatible with different virus production platforms and repeat filtration
- Fully synthetic transfection reagent formulation
- Identical in formulation to research-grade TransIT-VirusGEN™
- Includes release testing and quality documentation to streamline the process of ancillary material qualification, ensuring seamless transitions from discovery through large-scale manufacturing
Specifications
None (Promoterless) | |
293-derived Cells | |
Bottle | |
Store at -10 to -30°C | |
30 mL of transfection reagent in a clear bottle | |
Tranfsection reagent | |
HEK 293 cells | |
Synthetic, animal origin free and manufactured in the U.S. |
Sterile | |
Proprietary | |
Chemical Transfection | |
Cationic lipid and polymer based transfection reagent (non-liposomal) | |
Clear bottle | |
30 mL | |
High titer virus production (e.g. lentivirus and AAV) |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title